RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Income before tax

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.4B
P/E ratio
-3.6x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 2025-1,148-0.95%
Mar 31, 2024-1,159-21.36%
Mar 31, 2023-1,474-0.55%
Mar 31, 2022-1,482-14.76%
Mar 31, 2021-1,739-4.68%
Mar 31, 2020-1,824+8.70%
Mar 31, 2019-1,678+6.66%
Mar 31, 2018-1,573+40.91%
Mar 31, 2017-1,117+12.45%
Mar 31, 2016-993+140.14%
Mar 31, 2015-414-2259.95%
Mar 31, 201419-91.28%
Mar 31, 2013220+637.05%
Mar 31, 201230

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)